Vir Biotechnology Stock Price on December 24, 2024
| VIR Stock | USD 7.47 0.07 0.95% |
Below is the normalized historical share price chart for Vir Biotechnology extending back to October 11, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vir Biotechnology stands at 7.47, as last reported on the 27th of December, with the highest price reaching 7.64 and the lowest price hitting 7.33 during the day.
If you're considering investing in Vir Stock, it is important to understand the factors that can impact its price. Currently, Vir Biotechnology is somewhat reliable. Vir Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0224, which indicates the firm had a 0.0224% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Vir Biotechnology, which you can use to evaluate the volatility of the company. Please validate Vir Biotechnology's Coefficient Of Variation of 5849.88, risk adjusted performance of 0.0219, and Semi Deviation of 4.28 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%.
As of 12/27/2024, Stock Based Compensation is likely to grow to about 116.9 M, while Total Stockholder Equity is likely to drop slightly above 941.7 M. . At this time, Vir Biotechnology's Price Book Value Ratio is relatively stable compared to the past year. As of 12/27/2024, Price Earnings To Growth Ratio is likely to grow to 0.01, while Price Earnings Ratio is likely to drop (2.30). Vir Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of October 2019 | 200 Day MA 8.8473 | 50 Day MA 8.0058 | Beta 0.457 |
Vir |
Sharpe Ratio = 0.0224
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | VIR | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.93 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Vir Biotechnology is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vir Biotechnology by adding it to a well-diversified portfolio.
Price Book 0.8214 | Enterprise Value Ebitda 0.8951 | Price Sales 12.963 | Shares Float 92.5 M | Wall Street Target Price 29.5 |
Related Headline
Krystal Biotech Headline on 24th of December 2024
3 US Growth Stocks With Insider Ownership Expecting Up To 85... by simplywall.st
As the U.S. stock market inches higher in a holiday-shortened session, with indices like the Nasdaq Composite and SP 500 posting modest gains, investors are keeping a close eye on growth stocks that demonstrate robust potential amid fluctuating economic conditions. In this context, companies with high insider ownership can be particularly appealing, as significant insider stakes often signal confidence in the companys future prospects and alignment of interests between management and...
Vir Biotechnology Valuation on December 24, 2024
It is possible to determine the worth of Vir Biotechnology on a given historical date. On December 24, 2024 Vir was worth 7.35 at the beginning of the trading date compared to the closed value of 7.38. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vir Biotechnology stock. Still, in general, we apply an absolute valuation method to find Vir Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vir Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vir Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 7.39 | 7.52 | 7.26 | 7.34 | 771,107 | |
12/24/2024 | 7.35 | 7.45 | 7.15 | 7.38 | 413,977 |
| 7.27 | 7.43 | 7.17 | 7.40 | 788,104 |
| Backtest Vir Biotechnology | | | Vir Biotechnology History | | | Vir Biotechnology Valuation | Previous | Next |
Vir Biotechnology Trading Date Momentum on December 24, 2024
| On December 26 2024 Vir Biotechnology was traded for 7.40 at the closing time. Highest Vir Biotechnology's price during the trading hours was 7.43 and the lowest price during the day was 7.17 . The net volume was 788.1 K. The overall trading history on the 26th of December contributed to the next trading period price gain. The trading price change to the next next day price was 0.27% . The trading price change to current price is 0.14% . |
Vir Biotechnology Fundamentals Correlations and Trends
By evaluating Vir Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vir Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vir financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vir Biotechnology Stock history
Vir Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vir is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vir Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vir Biotechnology stock prices may prove useful in developing a viable investing in Vir Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 134.1 M | 129.3 M | |
| Net Income Applicable To Common Shares | 593.2 M | 622.9 M |
Vir Biotechnology Quarterly Net Working Capital |
|
Vir Biotechnology Stock Technical Analysis
Vir Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Vir Biotechnology Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Vir Biotechnology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vir Biotechnology December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Vir Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vir Biotechnology shares will generate the highest return on investment. By undertsting and applying Vir Biotechnology stock market strength indicators, traders can identify Vir Biotechnology entry and exit signals to maximize returns
Vir Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vir Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Vir Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vir to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0219 | |||
| Jensen Alpha | 0.0546 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.0067 | |||
| Treynor Ratio | 0.1717 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.